Skip to main content
. 2020 May 15;111(7):2451–2459. doi: 10.1111/cas.14441

TABLE 3.

Number (%) of deaths with malignancies other than gastric cancer as underlying causes in patients diagnosed with gastric adenocarcinoma in Sweden, 1970‐2014

Anatomic site Total gastric adenocarcinoma Cardia adenocarcinoma Noncardia adenocarcinoma
Total 4256 (100) 1600 (100) 2656 (100)
Lip, oral cavity, and pharynx 25 (0.6) 2 (0.1) 23 (0.9)
Digestive organs 2586 (60.8) 1481 (92.6) 1105 (41.6)
Esophagus 1601 (37.6) 1406 (87.9) 195 (7.3)
Colon, rectum, and anus 383 (9.0) 23 (1.4) 360 (13.6)
Liver and biliary passages 177 (4.2) 12 (0.8) 165 (6.2)
Pancreas 316 (7.4) 19 (1.2) 297 (11.2)
Lung (including trachea and bronchus) 262 (6.2) 15 (0.9) 247 (9.3)
Breast 124 (2.9) 4 (0.3) 120 (4.5)
Uterus 29 (0.7) 1 (0.1) 28 (1.1)
Ovary 48 (1.1) 2 (0.1) 46 (1.7)
Prostate 256 (6.0) 24 (1.5) 232 (8.7)
Bladder 73 (1.7) 10 (0.6) 63 (2.4)
Kidney 47 (1.1) 3 (0.2) 44 (1.7)
Thyroid 8 (0.2) 0 (0) 8 (0.3)
Hodgkin lymphoma 4 (0.1) 0 (0) 4( 0.2)
Non‐Hodgkin lymphoma 63 (1.5) 3 (0.2) 60 (2.3)
Leukemia 60 (1.4) 0 (0) 60 (2.3)
Others and unspecified 671 (15.8) 55 (3.4) 616 (23.2)